Month: October 2015

China will try to become prime supplier of artemisinin

At present, China provides most of the Artemisin anna raw material from which artemisinin, the active ingredient for Malaria treatment, is being extracted and purified. This constitutes about 70 % of the 180 tons world market. The remainder is produced by a chemo-fermentative process including metabolically engineered yeast (Sanofi, around 40 tons). The CAS Institute […]

CAS Institute of Biophysics develops nanozyme strip based on magnetic particles for fast detection of virus infections, e. g., Ebola

The immunochromatographic strip developed by YAN Xiyun and colleages is based on the use of magnetic Fe3O4 nanoparticles which, loaded with appropriate antibodies, could detect the glycoprotein of Ebola virus (EBOV) at 1 ng/mL concentrations which is 100-fold more sensitive than the standard strip method. This sensitivity is comparable with ELISA, but much faster (within 30 min) […]

CAS Chengdu Institute of Biology group develops pathway for n-caproate from lactate

The group around TAO Yong has used a unique microbiome that metabolizes lactate rather than ethanol for the production of n-caproate production. The microbial community was obtained from a fermentation pit used for the production of Chinese strong-flavour liquor (CSFL) and consisted to > 70 % of Clostridia. This microbiome was able to produce n-caproate […]

First Nobel Prize (Physiology or Medicine) ever for China: to Mrs Professor Yoyo TU for development of artemisinin as Malaria therapy

Professor TU is the head of the Chinese Academy of Traditional Medical Sciences in Beijing. Based on findings of traditional Chinese medicine (TCM) for the treatment of malaria, she started to extract the plant Artemisia anna for active components and was the first to discover artemisinin as the active principle. Artemisinin is successfully used to […]

Scroll to top